BRPI0614412A2 - composto, e, composição farmacêutica - Google Patents

composto, e, composição farmacêutica

Info

Publication number
BRPI0614412A2
BRPI0614412A2 BRPI0614412A BRPI0614412A BRPI0614412A2 BR PI0614412 A2 BRPI0614412 A2 BR PI0614412A2 BR PI0614412 A BRPI0614412 A BR PI0614412A BR PI0614412 A BRPI0614412 A BR PI0614412A BR PI0614412 A2 BRPI0614412 A2 BR PI0614412A2
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BRPI0614412A
Other languages
English (en)
Inventor
Andrew Fensome
Casey Cameron Mccomas
Edward George Melenski
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0614412A2 publication Critical patent/BRPI0614412A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0614412A 2005-07-29 2006-07-27 composto, e, composição farmacêutica BRPI0614412A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70400905P 2005-07-29 2005-07-29
PCT/US2006/029125 WO2007016212A1 (en) 2005-07-29 2006-07-27 Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof

Publications (1)

Publication Number Publication Date
BRPI0614412A2 true BRPI0614412A2 (pt) 2016-11-22

Family

ID=37309001

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0614412A BRPI0614412A2 (pt) 2005-07-29 2006-07-27 composto, e, composição farmacêutica

Country Status (22)

Country Link
US (1) US7291643B2 (pt)
EP (1) EP1910285A1 (pt)
JP (1) JP5185114B2 (pt)
KR (1) KR20080031915A (pt)
CN (1) CN101233104A (pt)
AR (1) AR056005A1 (pt)
AU (1) AU2006275833B2 (pt)
BR (1) BRPI0614412A2 (pt)
CA (1) CA2612977A1 (pt)
CR (1) CR9627A (pt)
EC (1) ECSP088147A (pt)
GT (1) GT200600336A (pt)
HN (1) HN2008000135A (pt)
IL (1) IL188314A (pt)
MX (1) MX2008001338A (pt)
NO (1) NO20076683L (pt)
PE (1) PE20070404A1 (pt)
RU (1) RU2007148077A (pt)
SA (1) SA06270246B1 (pt)
TW (1) TW200734302A (pt)
UA (1) UA92500C2 (pt)
WO (1) WO2007016212A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
PE20070182A1 (es) * 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
TW200848021A (en) * 2007-03-06 2008-12-16 Wyeth Corp Sulfonylated heterocycles useful for modulation of the progesterone receptor
TW200848019A (en) * 2007-03-06 2008-12-16 Wyeth Corp Aryl sulfonamides useful for modulation of the progesterone receptor
US20090170823A1 (en) * 2007-12-20 2009-07-02 Duramed Pharmaceuticals, Inc. Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception
JP6293770B2 (ja) 2012-11-05 2018-03-14 ナント ホールディングス アイピー,エルエルシー ヘッジホッグシグナル伝達経路阻害剤としての環状スルホンアミド含有誘導体

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680413A (en) * 1986-01-17 1987-07-14 Nippon Soda Co., Ltd. Process for the production of 3-phenyl-4-cyanopyrroles
US5310938A (en) * 1987-07-29 1994-05-10 American Cyanamid Company Substituted arylpyrrole compounds
EP0339342A1 (de) * 1988-04-23 1989-11-02 Bayer Ag N-Substituierte N-Amino-pyrrole
GB8903592D0 (en) * 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents
DE4036645A1 (de) 1990-11-16 1992-05-21 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung
JP2699024B2 (ja) 1990-11-22 1998-01-19 富士写真フイルム株式会社 新規な色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料
US5236925A (en) * 1991-10-24 1993-08-17 American Home Products Corporation Fused pyrimidines as angiotensin II antagonists
US5187168A (en) * 1991-10-24 1993-02-16 American Home Products Corporation Substituted quinazolines as angiotensin II antagonists
WO1994017059A1 (fr) 1993-01-29 1994-08-04 Nippon Soda Co., Ltd. Derive heterocyclique
ES2259795T3 (es) * 1995-06-07 2006-10-16 Nippon Shinyaku Company, Limited Derivados de pirrol y composicion medicinal.
US6013421A (en) * 1996-07-19 2000-01-11 Fuji Photo Film Co., Ltd. Silver halide photographic light-sensitive material and image-forming method
US20010007867A1 (en) * 1999-12-13 2001-07-12 Yuhpyng L. Chen Substituted 6,5-hetero-bicyclic derivatives
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
OA12552A (en) * 2001-03-09 2006-06-06 Pfizer Prod Inc Triazolopyridines as anti-inflammatory agents.
WO2002072576A1 (en) * 2001-03-09 2002-09-19 Pfizer Products Inc. Benzimidazole anti-inflammatory compounds
ATE304009T1 (de) * 2001-04-04 2005-09-15 Pfizer Prod Inc Neue benzotriazole mit entzündungshemmender wirkung
CA2505361A1 (en) 2002-11-11 2004-05-27 Bayer Healthcare Ag Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
EP1594438B1 (fr) 2003-02-12 2013-07-17 L'Oréal Utilisation d'un inhibiteur de 15-hydroxy prostaglandine déshydrogénase pour favoriser la pigmentation de la peau ou des phanères
JP5108506B2 (ja) 2004-04-27 2012-12-26 ワイス・エルエルシー シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
GT200500183A (es) 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos

Also Published As

Publication number Publication date
NO20076683L (no) 2008-02-04
HN2008000135A (es) 2010-08-19
JP2009502947A (ja) 2009-01-29
PE20070404A1 (es) 2007-05-10
AR056005A1 (es) 2007-09-12
JP5185114B2 (ja) 2013-04-17
CN101233104A (zh) 2008-07-30
ECSP088147A (es) 2008-02-20
US7291643B2 (en) 2007-11-06
KR20080031915A (ko) 2008-04-11
IL188314A0 (en) 2008-04-13
CR9627A (es) 2008-03-06
RU2007148077A (ru) 2009-09-10
WO2007016212A1 (en) 2007-02-08
UA92500C2 (ru) 2010-11-10
MX2008001338A (es) 2008-03-25
AU2006275833B2 (en) 2012-04-26
EP1910285A1 (en) 2008-04-16
CA2612977A1 (en) 2007-02-08
TW200734302A (en) 2007-09-16
US20070027126A1 (en) 2007-02-01
GT200600336A (es) 2007-05-28
SA06270246B1 (ar) 2010-11-22
IL188314A (en) 2012-09-24
AU2006275833A1 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
RU2398586C3 (ru) Фармацевтическая композиция
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
BRPI0511900A (pt) composições farmacêuticas
PL1954684T3 (pl) Związek oksazolowy i kompozycja farmaceutyczna
BRPI0613033A2 (pt) composição oral
NO20053161D0 (no) Mikrobedrepende sammensetning.
ITMI20050728A1 (it) Formulazione innovativa
NO20075628L (no) Farmasøytiske formuleringer
EP1788047A4 (en) WATER REPELLENT / OIL-REPELLING COMPOSITION
BRPI0608885A2 (pt) composto de isômero c de sdz-rad, composição farmacêutica, e, embalagem farmacêutica
ATE535505T1 (de) Landwirtschaftliche zusammensetzung
NO20055686D0 (no) Sammensetning
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
DK1725218T3 (da) Farmaceutisk sammensætning omfattende pimobendan
DK1957073T3 (da) Lægemiddel
DK2033629T3 (da) Fast farmaceutisk sammensætning omfattende valsartan
DK1741339T3 (da) Pesticid sammensætning
DE602005017191D1 (de) Geruchsreduzierte waschstück-zusammensetzung
DE602006020863D1 (de) Antimikrobielle zusammensetzung
EP1937255A4 (en) PHARMACEUTICAL COMPOSITION
BRPI0611748A2 (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
DE502006001779D1 (de) Allylorganopolysiloxane aufweisende vernetzbare zusammensetzungen
BRPI0614413A2 (pt) composto, e, composição farmacêutica

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B11Z Dismissal: petition dismissal - article 216, par 2 of industrial property law

Free format text: REFERENTE A PETICAO NO 20080015065/RJ DE 29/01/2008.

B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: O DESPACHO 6.7 DA RPI NO 2140 DE 10/01/2012 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 - AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.

B11M Decision cancelled [chapter 11.13 patent gazette]

Free format text: O DESPACHO 11.6.1 DA RPI NO 2186 DE 27/11/2012 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 - AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]